COMMUNIQUÉS West-GlobeNewswire

Motif Bio Appoints Stephanie Noviello, MD, MPH as Vice President, Clinical Development
09/05/2018
NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Stephanie Noviello, MD, [...]
ThromboGenics Business Update - Q1 2018
09/05/2018
Press release 9 May 2018 Regulated Information Advancing Diabetic Eye Disease Portfolio Positive Initial Topline Data from Phase 1/ 2a Clinical Study evaluating THR-317, anti-PlGF, for the Treatment of Diabetic Macular [...]
ERYTECH to Host First Quarter 2018 Conference Call and Business Update
09/05/2018
LYON, France, May 09, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018
09/05/2018
Curetis to Hold Annual General Shareholders' Meeting on June 21, 2018 Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, May 9, 2018, 07:00 am CEST / 01:00 am EDT - Curetis N.V. (the " Company " [...]
IBA SA : IBA Business Update - First Quarter 2018
09/05/2018
IBA Business Update - First Quarter 2018 21 ongoing proton therapy projects in 2018 Louvain-La-Neuve, Belgium, 9 May 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy [...]
IBA SA : IBA Déclaration Intermédiaire - Premier Trimestre 2018
09/05/2018
IBA Déclaration Intermédiaire - Premier Trimestre 2018 21 projets de protonthérapie en cours d'installation en 2018 Louvain-La-Neuve, Belgique, 9 mai 2018 - IBA ( Ion Beam Applications SA , EURONEXT), le premier [...]
argenx reports first quarter 2018 financial results and provides business update
09/05/2018
May 9, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment [...]
Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider
09/05/2018
SYDNEY, Australia and MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced the execution of a commercial [...]
Evelo Biosciences Announces Pricing of Initial Public Offering
09/05/2018
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO ) (“Evelo”) today announced the pricing of its initial public offering of 5,312,500 shares of common stock at a public offering [...]
MediciNova to Present at the UBS Global Healthcare Conference in New York
09/05/2018
LA JOLLA, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
IntelGenx Closes Private Placement Financing
08/05/2018
SAINT LAURENT, Quebec, May 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX ) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of the previously announced offering by way of private [...]
Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
Conference Call and Webcast on Wednesday, May 9 at 8:30am Eastern Time REHOVOT, Israel, May 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix” or the “Company”), a clinical stage [...]
Reata Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results and an Update on Development Programs
08/05/2018
CATALYST TRIAL IN CTD-PAH FINAL SAMPLE SIZE SET AT 200; TOP-LINE DATA EXPECTED IN THE FIRST HALF OF 2020 PHOENIX TRIAL INTERIM DATA FOR ADPKD AND IGA NEPHROPATHY COHORTS AT ERA-EDTA IN MAY; FULL DATA FOR THESE COHORTS [...]
Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore
08/05/2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year [...]
Emblem Announces Settlement With Dissenting Shareholder
08/05/2018
TORONTO, May 08, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (" Emblem " or the " Corporation ") announces that it has agreed to issue an aggregate of 482,758 common shares in the capital of Emblem (the “ [...]
Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
08/05/2018
Total revenue of $90.4 million, a 57% increase over 2017 Net product sales of $89.1 million, a 58% increase over 2017 Operating earnings of $31.4 million, an 87% increase over 2017 Diluted earnings per share (GAAP) of $ [...]
Versartis Reports First Quarter 2018 Financial Results
08/05/2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (Nasdaq: VSAR ), an endocrine-focused biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2018. “We [...]
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
08/05/2018
CHARLESTON, S.C., May 08, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) announced today at its annual and special shareholders’ meeting held on May 8, 2018, that the individuals noted below [...]
ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update
08/05/2018
End-of-Phase 2 Meeting with the U.S. FDA Scheduled for the Last Week of June to Review Gencaro Phase 2 Data and Future Development Plan WESTMINSTER, Colo., May 08, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: [...]

Pages